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Summary 
Background: Perinatal anxiety and depression are widespread, with up to 20% of women affected 
during pregnancy and after birth. In the UK, management of perinatal mental health falls under the 
remit of general practitioners (GPs).  We reviewed the literature on GPs’ routine recognition, 
diagnosis and management of anxiety and depression in the perinatal period. 
Method: A systematic search of Embase, Medline, PsycInfo, Pubmed, Scopus and Web of Science 
was conducted. Studies were eligible if they reported quantitative measures of GPs’ or Family 
Physicians’ assessment, recognition and management of anxiety or depression in pregnancy or 
postpartum.  
Results: Thirteen papers, reporting ten studies, were identified from the US, Australia, UK, 
Netherlands and Canada. All reported on depression; two included anxiety disorders. Reported 
awareness and ability to diagnose perinatal depression among GPs was high. GPs knew about and 
used screening tools in the UK but less so in US settings. Antidepressants were the first line of 
treatment, with various SSRIs considered safest. Counseling by GPs and referrals to specialists were 
common in the postnatal period, less so in pregnancy. Treatment choices were determined by 
resources, attitudes, knowledge and training.  
Conclusions: Data on GPs’ awareness and management of perinatal depression was sparse and 
unlikely to be generalizable. Future directions for research are proposed; such as exploring the 
management of anxiety disorders which are largely missing from the literature, and understanding 
more about barriers to disclosure and recognition in primary care. More standardized training could 
help to improve recognition and management practices.  
Keywords: postnatal depression, general practice, pregnancy, mental health, systematic review. 
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Background 
The perinatal period for mental illness lasts from the onset of pregnancy until twelve months after 
birth. Perinatal depressive and anxiety disorders are common: about 18% of pregnant women have 
depression during pregnancy 1 and 13-19% of new mothers have major or minor depression in the 
first year after delivery.1,2 Anxiety is also common, with 8% experiencing generalized anxiety disorder 
(GAD), 3% experiencing panic disorder and 3% experiencing obsessive compulsive disorder (OCD) in 
pregnancy. Following birth, up to 8% experience GAD, 9% of women experience panic, 2-3% 
experience new onset OCD and 3% experience post-traumatic stress disorder (PTSD).3-6 
Perinatal anxiety and depression can have a damaging impact on women and their families if 
left untreated. Mental illness is one of the leading indirect causes of death for women 6 weeks to 
one year postpartum.7-9 The United Kingdom’s (UK) National Institute for Health and Care Excellence 
(NICE) has clear guidance about effective management.10 Perinatal mental health is a strategic 
priority for health policy: while much data on costs are still missing, a recent UK report found that 
the annual cost to UK society of perinatal depression was £73,822 per case ($104,574) 11, of which 
70% was due to the increased risk of psychological and developmental disturbances in children.12  
In the UK National Health Service (NHS), primary care is the first and continuing point of care 
for patients. It comprises general practitioners (GPs), midwives for pregnant women, and health 
visitors (UK community nurses specialized in maternal and child heath) for new mothers. Women 
mostly see their midwife for routine antenatal care.  Midwives usually discharge women 10-14 days 
after birth when health visitors and GPs become the women’s primary contact for health care. 
Women generally see their GP for a routine check-up at 6-8 weeks postpartum. Guidelines from 
NICE recommend that all primary care practitioners ask about possible depression and anxiety when 
women first have contact in pregnancy and at all subsequent perinatal contacts.10 If a possible 
perinatal mental illness is identified by any health professional, NICE recommends the GP as the first 
line of assessment and management.10  
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Despite GPs being in the front line of care available in the UK for the mental health of 
perinatal women, and the UK Royal College of General Practitioners (RCGP) recognizing perinatal 
mental health as a clinical priority,13 very little research has looked directly at what GPs know about 
perinatal depression and anxiety disorders; how well they recognize and differentiate disorders; and 
how they treat and manage them. A small study assessing the use of the Edinburgh Postnatal 
Depression Scale (EPDS) 14 for identifying depression in primary care suggested that GPs missed 
many cases of depression in postnatal women (recognizing 13 cases out of 30), although they did 
recognize more cases than any other professional group.15 One study used GP patient records to 
investigate prevalence rates of depression as recorded in general practice and found 13.3% of 
perinatal women had depression noted in their medical records, and 3.7% had anxiety.16 This rate of 
depression is consistent with survey-based studies, but anxiety rates are lower than expected.  
Historically, studies have suggested that many cases of perinatal depression and anxiety are 
missed in general practice 15,17-19 and those that are identified are undertreated 15,17-22.  The aim of 
this review was to synthesize the available information from quantitative observational studies on 
general practitioners’ (or the equivalent, family physicians, in the US and Canada) routine practice 
for the assessment, recognition, and management of perinatal depression and anxiety. Studies 
reporting on severe mental illness such as psychosis are not considered, and results from qualitative 
studies are assessed and reported elsewhere. Understanding GPs’ current routine activity in this 
area will highlight avenues for improvement in identification and treatment of women with these 
perinatal disorders. 
Method 
Search Strategy 
A systematic search was conducted conforming to the Preferred Reporting Items for Systematic 
Reviews and Meta-Analysis (PRISMA) statement 23, between October and December 2014 on 
Embase, Medline, PsycInfo, Pubmed, Scopus and Web of Science. No protocol was registered. A 
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second search was made in May 2016 for papers published from 1st Jan 2015 to 10th May 2016 to 
ensure the results presented were current. Broad search terms were used to identify anxiety and 
depressive disorders, related to pregnancy and the postnatal period, specifying general practitioners 
and the themes of diagnosis and treatment to ensure as many articles as possible were identified 
(Appendix 1). Forwards and backwards searches of reference lists and citations were made, which 
identified one further paper to be considered for the review. 
The first search returned 8210 papers and the second returned 2439 (Figure 1). After 
removing duplicates and inspection of the title of each paper for relevance, the abstracts of 730 
papers were screened and 33 papers were scrutinized in full. Screening of titles and abstracts was 
performed by FE, full text screening by FE & EF and eligibility of papers was agreed among all 
authors.  
Eligibility 
Papers were eligible for inclusion if they reported quantitative measures of General Practitioners’ 
(GPs; UK, Australia and Netherlands) or Family Physicians’ (FPs; US and Canada) recognition, 
assessment or management of perinatal depression or anxiety in primary care (all results are 
reported using the term “GPs”). Papers were ineligible if they were published before 1990 (as these 
would not reflect current practice), did not report original research, were not published in English, 
did not included GPs or FPs as main participants, did not report GP or FP findings as a separate 
group, reported trials or interventions rather than routine practice, reported results qualitatively 
rather than quantitatively (these are reviewed elsewhere), or if they addressed multiple perinatal 
illnesses (including physical). No papers were rejected solely on the basis of not being published in 
English. 
- Figure 1 about here - 
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Quality Assessment 
The methodological quality of each paper was assessed based on a revised version of the “STROBE” 
rating scale for evaluating quantitative studies (Strobe-statement.org, 2015). The rating scale was 
revised to include only items relevant to the papers being reviewed (Appendix 2). Two authors 
independently assessed quality (EF and FE). Response rates in the surveys used were examined as a 
proxy for risk of bias within studies.  
Data extraction process 
Data from studies was extracted into a table in Excel. The following information was extracted: Study 
title, country of origin, quality score, response rate, number of participants, study design, focus on 
pregnancy or postpartum, any results pertaining to diagnosis/recognition; attitudes or experience; 
treatments; and barriers and facilitators. No meta-analysis was performed as included studies did 
not use comparable measures.  
Results  
Studies 
Thirteen papers were found which met inclusion criteria, reporting ten separate studies (Table 1).24-
36 Eleven out of thirteen papers investigated depression only; two papers reported on anxiety 
disorders in addition, but did not separate results for anxiety and depression.34,35 Papers were 
published between 2005 and 2016. Four papers were based on UK data,24,30 34,35 four papers were 
from the USA,28,31,32,36 four from Australia (one combined with data from Canada) 25-27,29 and one 
from the Netherlands.33 Nine papers reported survey results from a combined total of 915 GPs or 
FPs and one reported survey results from 199 GP practices.24 Three studies reported on data from 
GP patient records; one examined 411 entries in GP records,29 and another two papers reported 
data from GP records of 8991 and 2234 women from the same cohort.34,35 Where several types of 
health-care professionals were surveyed, results are reported from GPs and FPs only. Three papers 
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reported on care during pregnancy,25,33,35 five papers focused on the postpartum period,28,29,31,32,36 
and five studied both pregnancy and the postpartum period.24,26,27,30,35 
Ten papers used a questionnaire or survey to gather information from participants, of which 
four papers also included a vignette. All the studies developed and used their own measures. One 
study reported on data from the Australian “Bettering the Evaluation and Care of Health” study 
(BEACH) in which 1000 randomly selected GPs annually record details of 100 consecutive 
encounters.37 Two papers reported on GP data from the “Born in Bradford Cohort” which recruited 
12,450 women at 26-28 weeks of pregnancy.34,35  
- Insert Table 1 about here – 
Quality Assessment and Risk of Bias  
Quality scores ranged from 10-23; 10 of the 13 papers were methodologically well conducted and 
reported, scoring ≥19 out of 24. Three papers scored 10 to 15.26,29,30 These papers were short reports 
with little methodological information. No papers were excluded from the review on the basis of 
quality scores due to the small number of studies in this area. No unpublished studies were included. 
Survey response rates, and dropout rates are shown in Table 1, and ranged from 18% to 79% 
suggesting low external validity both within studies and across the included studies as a group. There 
is therefore a high risk that results are not representative of the source populations of GPs or FPs 
within each country.  
Themes from the included studies 
Results from the included studies were arranged into three main themes, with seven subthemes. 
The studies contributing to each subtheme are shown in Table 2.  
- Insert Table 2 about here -  
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Theme 1: Assessment and Recognition  
Prevalence of perinatal depression and anxiety in general practice 
Three studies reported on how often GPs saw women or recorded perinatal anxiety and depression, 
and one on whether GPs felt these disorders were their responsibility.  In an Australian study, 95% of 
GPs had cared for perinatal women in the past 6 months, and over half of the sample had seen 10-19 
perinatal women in that time.26 The Australian BEACH GP study reported data from GP patient 
records. Postnatal depression was recorded during 411 encounters between 1998 and 2005, 
representing a rate of 30 per 1000 encounters in women aged 25-44 years.29 Depression was coded 
as the main reason in 60% of encounters, with other reasons being documented as postnatal check-
up (7%), weakness/tiredness (6%) and psychological follow up (6%) 29. A British study of GP records 
found a recorded prevalence rate for anxiety and depression of 9.5% during pregnancy and 13.1% in 
the first postnatal year 34. White British women had double the rate of recorded disorders compared 
with minority ethnic women 34. The recorded incidence rate was 37.5 per 1000 person years at risk 
in pregnancy and 102.4 per 1000 person years at risk in the first postnatal year34.  
 One study found the majority of GPs felt responsible for diagnosing and treating postnatal 
depression 31.  GPs agreed that recognizing and treating maternal depression was their 
responsibility, and strongly agreed that they felt comfortable talking about depression with 
mothers.31 
Awareness 
Awareness of depression was reported in two papers by presenting a vignette to GPs and scoring 
them based on recognition that “Mary” was depressed, needed help and on the ability to choose 
appropriate treatments.26,27  To the question “What's wrong with Mary?” 95% of GPs selected at 
least one depression diagnosis.26 When compared to midwives and maternal child health nurses, GPs 
were significantly more likely than midwives to think help was needed for mood disorder (92% v 
83%; p<0.05) and GPs were significantly more likely than midwives to endorse prescribing 
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antidepressants (antenatally, 77.8% vs 50.2% p<0.05; postnatally, 97% v 90.4% p<0.05).27 Depression 
was more likely to be recognized postnatally compared to antenatally by all health care 
professionals.26,27 
Routine enquiry and assessment 
A UK study surveyed GP practices about how adherent they were with national policy.24 
With regard to antenatal enquiry about previous history of depression, psychosis, psychopathology 
or a family history of affective psychosis, they found that 88% of GP practices undertook routine 
assessment of previous history of depression, 81% asked about a history of puerperal psychosis, 65% 
about a history of psychopathology and 65% about a family history of affective psychosis.24 Ninety-
five percent of practices used the EPDS 14 as a screening tool for depression postnatally. 24  In 
contrast to this, a US based study36  found that while 70% of GPs always or often screened at 
women’s postpartum checkups, only 10% of those who screened used the EPDS and 8% used the 
Postpartum Depression Checklist.38 Others (82%) preferred to use a diagnostic interview technique 
for screening.36 
A UK study looking at GP records found that fewer than 13% of women had codes indicating 
screening and case-finding for anxiety and depression in the first postnatal year, and twice as many 
white British women had these codes compared to minority ethnic women.34 When women in this 
study were checked for anxiety and depression using the General Health Questionnaire-28, it was 
estimated that between 31% and 46% of individuals with anxiety and depression in pregnancy were 
missed by GPs.34  
Two US studies reported on  familiarity with screening tools such as the EPDS, the 
postpartum depression screening scale (PDSS),39 and the Patient Health Questionnaire-9 (PHQ-9),40 
and determinants of physician screening practices.28 Familiarity with screening tools was low in 
these studies, with the majority of physicians never having used them.28,36 The majority of physicians 
preferred symptom review inquiring directly about the patient’s mood, prior psychiatric history and 
observing the mother’s interaction with her baby. 28,36 Senior doctors were more familiar with 
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screening tools than doctors in training 28. Being female, having training in postnatal depression, and 
agreement that PND is common enough to warrant screening were all associated with more 
frequent screening 36.  
Theme 2: Management of Depression and Anxiety in Pregnancy  
Medication choices 
Five papers looked at the management of depression in pregnancy. One study compared 
GPs in Australia and Canada, asking them what they would prescribe for a woman using 
antidepressants at the time of becoming pregnant.25 This found 60% of Australian GPs and 72.4% of 
Canadian GPs said they would continue the antidepressant medication.25 This study found that the 
perceived safety of antidepressants in pregnancy, and confidence in giving advice, was higher in 
Canada, with 83% of Canadian GPs perceiving antidepressants as safe in pregnancy compared to 
42% of Australian GPs.25 
In a sample of Dutch GPs, opinions on continuing antidepressant medication for pregnant 
women, lowering the dose, or stepping down, varied widely, although 92% of GPs never advised 
substituting one drug for another, and 55% never advised substitution of psychotherapy for 
medication.33 Paroxetine and fluoxetine were the first choice drugs in the Dutch study.33 Ninety-six 
percent of GPs believed antidepressants were associated to some extent with increased risk of birth 
defects and that the negative effects on the child were a reason to avoid antidepressants.33 
A Scottish study looked at the treatments offered by GP practices for new cases of 
depression in pregnancy.24 The common choices were medication (68%), cognitive behavioral 
therapy (CBT; 46%), interpersonal therapy (IPT; 41%), complementary therapies (23%) and St John's 
Wort (9%).24 In a second Scottish study of drugs chosen in the first trimester of pregnancy, the first 
choice was fluoxetine, recommended by 63% GPs and avoided by 6%.30 Amitriptyline, sertraline and 
citalopram were also recommended, whereas, paroxetine, venlafaxine and mirtazapine were 
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primarily avoided.30 Reasons for choosing drugs were given as: low teratogenicity risk or considered 
safe (53%), experience with the drug (38%), and good efficacy (9%). The reasons given for avoiding 
certain drugs were given as: risk to the baby (31%) or a lack of experience with the drugs (22%).30 
A British study examining GP patient records identified 2234 women with anxiety and 
depression during pregnancy or postnatally.35 In pregnancy, 298 (13%) of these women had 
prescriptions issued for anxiety or depression; 86% of these women had an antidepressant (69% 
were SSRIs) and 23% of them had an anxiolytic prescribed. 174 women (58%) did not have a 
prescription issued after the end of the first trimester.35 Only 26 of these 174 women (15%) had a 
subsequent code indicating provision of a non-pharmacological treatment during their pregnancy 35.  
Information on medication choices 
Two studies reported on GPs’ sources of information about the safety of medication in 
pregnancy. In a Dutch study, GPs consulted the teratogen information service, pharmacists, the 
Dutch national formulary, drugs manufacturers, and looked on the internet for guidelines and 
scientific evidence.33 However, only 1 of 130 of these GPs (<1%) had a written policy for depression 
or anxiety medication in pregnancy.33 In a Scottish study, GPs reported consulting the British 
National Formulary (31%), manufacturer’s advice (28%) and specialists (16%).30 
Theme 3: Management of Postnatal Depression 
Seven papers reported on the treatment of postnatal depression.  
Treatment choices 
The main options for treatment which were reported in four studies were antidepressant 
medication, counseling, and referral to others, such as psychiatrists, psychologists, psychotherapists, 
social workers or support groups (Table 3). Medication was the most common option (57-92%), 
followed by counseling (57-85%) and referrals (1-85%).24,26,29,31 Between 7 and 61% reported giving 
advice on behavior change.29,31 In addition to the treatment options in Table 3, 64% of GP practices 
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in a Scottish study offered support to family members and 39% of GP practices said they could refer 
women to an inpatient mother and baby unit.24  
- Insert Table 3 about here – 
A range of antidepressants were endorsed as suitable for postnatal depression. In an Australian 
study, sertraline was prescribed at 22% of encounters, citalopram at 7% and paroxetine at 5%.29 In a 
Scottish study on prescribing during breastfeeding, fluoxetine was both chosen (44%) and avoided 
(28%) by GPs, with citalopram, doxepin and venlafaxine being the next most commonly chosen, and 
avoided, drugs.30 The reasons given for drug choices were their perceived safety (50%), the GP’s 
experience of drug (28%), and the perceived effectiveness of the drug (9%). The reasons given for 
avoiding certain drugs were a lack of data regarding safety (44%), a lack of experience (9%), or the 
drug not being effective (6%).30 
Determinants of Treatment Choices 
Two studies reported on determinants of treatment choices (1 American and 1 Australian). 
Perceived barriers to treatment choices were resources being unavailable, the reluctance of 
patients, family, language or beliefs, financial constraints on the part of the patient, and denial by 
the patient of the condition.26 Physician attitudes, namely a favorable perception of mental health 
services, self-efficacy, knowledge, and level of postgraduate training, influenced depression 
management practices.32 Physicians with better training and higher levels of knowledge were more 
likely to actively manage postnatal depression as they were more confident, more comfortable and 
felt greater responsibility.32  
Discussion  
To our knowledge, this is the first systematic review of studies looking at how GPs recognize 
and treat perinatal anxiety and depression in the course of their routine practice. A central finding is 
that there is a lack of evidence in this area and, crucially, the majority of results describe how GPs 
recognize and manage perinatal depression, with no studies reporting separately on anxiety 
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disorders. The lack of research on GPs’ routine practice highlights many opportunities for new 
research avenues.  
Goldberg and Huxley  proposed a model of levels of recognition or management of mental 
illness in the primary care setting, which is relevant to countries where GPs act as a gatekeeper to 
more specialist services, such as in the UK, Australia or Netherlands.41 The first level is the presence 
of mental health problems in the community, the next two levels represent patient presentation and 
then recognition in primary care, and the highest two levels are referral and admission to specialist 
psychiatric care. In order to pass from one level to another the patient must pass through various 
“filters”, such as attending in primary care and having the symptoms identified by the GP. 
If we consider this model for perinatal anxiety and depression, we can see clear opportunities 
for future research to understand more about each of the “filters”. For example, results from studies 
which explore the issues that facilitate or hinder patient self-identification, help-seeking and 
disclosure in primary care should be integrated with the GP perspective on patient disclosure. Many 
qualitative studies have looked in-depth at women’s barriers to help-seeking, but there is little 
literature which describes barriers to disclosure from GPs’ perspective.22,42 
Recognition 
A second avenue for intervention is the potential for increased recognition of symptoms by 
GPs when patients first present, by using screening tools, improving communication skills, or 
changing GPs’ training. Well-validated screening tools exist for perinatal depression, which have 
been used in primary care populations,15,43,44 but a majority of GPs are not using these particular 
tools routinely 36,45. Our findings suggest that GPs regularly see perinatal women, and appear to be 
aware of and take responsibility for recognizing and managing perinatal anxiety and depression. 
Respondents in the survey studies reported high rates of screening in their clinics, however, 
examination of UK GP records showed screening was recorded in only 13% of patient records,34 
highlighting a discrepancy between the two sources of data, potentially due to high response bias in 
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the survey studies. One study using GP records reported an estimated rate of missed cases of 31-
46%,34 suggesting there is still a diagnosis gap for perinatal depression in general practice, and 
research suggests that women from black and ethnic minority groups have their perinatal mental 
health needs missed more than white women.46  
Population-based screening has been criticized for not being cost-effective due to the large 
number of false-positives.47 Several trials have examined the benefits of incorporating screening 
tools into general practice, but found only modest improvements in clinical outcomes. 48,49 Finding 
women who “screen positive” for depression is only helpful if those women are appropriately 
assessed, diagnosed and successfully treated.50 Qualitative research suggests that women prefer to 
only disclose symptoms, even on a screening tool, in a context of integrated and continuous care, 
with a known and trusted professional.42 Future research could therefore be directed towards GPs’ 
communication skills training, to boost the chance of symptom disclosure by perinatal women at 
both routine and opportunistic consultations. 
Effective Treatment 
Given recognition of perinatal depression and anxiety, effective treatment will depend on GP 
resources, attitudes or knowledge, patient reluctance or desire for treatment, and locally available 
specialist services. Some studies have suggested that even when depressive symptoms are disclosed 
or recognized, many women fail to receive effective treatment.21,22 
Studies have shown that psychological interventions delivered in primary care are effective in 
reducing depressive symptomatology,51-53 but in the UK at least, GPs report having few avenues to 
refer women for timely non-pharmacological treatment.54  In our findings, antidepressant 
medication was the primary method of treatment in pregnancy, although there was some evidence 
that antidepressant medications were stopped during pregnancy, with few non-pharmacological 
alternatives being offered, which could lead to a significant risk of relapse.55 Postnatally, GPs favored 
a range of treatments, endorsing both medication and psychological therapies for depression, with a 
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smaller number reporting that they would refer to other mental health specialists and support 
groups. Although SSRIs were largely favored, there was no consensus among practitioners about the 
exact choice of antidepressant in either pregnancy or breastfeeding, with respondents both favoring 
and avoiding the same range of drugs. The range of information sources consulted by GPs on the 
safety of drugs in pregnancy and breastfeeding suggests that the majority of GPs do not have clear 
guidelines easily to hand.  
GPs described prescribing anti-depressants in the absence of other options,54 but women 
are often reluctant to take them if pregnant or breastfeeding,56 which could impact on adherence to 
treatment. In real world primary care settings, the rate of complete recovery from depression is low, 
at around 30% following antidepressant treatment and slightly higher following psychological 
interventions.43 One review suggested that given the current drop-offs in the care pathway at the 
filters of clinical recognition, and adequate treatment, only 3-6% of women with perinatal 
depression are achieving full remission.43  
There is therefore room for substantial improvement in current provision of primary care for 
women with perinatal depression and anxiety. Better continuity of care, together with more timely 
access to non-pharmacological therapy, would appear likely to produce the greatest gains in 
women’s quality of life, due to aiding disclosure of symptoms and adherence to treatment. 
Additionally, more research is also critically needed to extend our understanding to all common 
perinatal mental illnesses, such as anxiety and PTSD, given that their combined prevalence among 
perinatal women equals or exceeds the prevalence of depression. Finally, more research is required 
to understand the gap between detection levels in white and black or ethnic minority women. 
Clinical Implications 
Confidence in recognizing and managing perinatal depression was predicted by favorable 
attitudes, levels of knowledge and postgraduate training. More research to understand attitudes, 
motivators and barriers to recognition and treatment of perinatal depression in general practice, 
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and the role of additional training, would be valuable.  In the UK, the RCGP recently published a 
report that recommends specific perinatal mental health training provision for qualified GPs, and 
incorporation of competencies relating to perinatal mental health into GP training programs.13 
However, it is important that when training programs are developed they are adequately evaluated 
to assess their impact on outcomes including rates and recovery from perinatal depression. 
The finding that there is no consensus among GPs about which antidepressants to prescribe 
to perinatal women may reflect the fact that national guidelines, such as UK NICE guidelines, 
recommend classes of drugs, such as SSRIs, rather than specific drugs.10 Also of interest is the range 
of sources of information consulted by GPs when choosing a suitable drug. It would be useful if GPs 
knew that this information were readily available from one source. Good information regarding 
specific drug use in pregnancy is available in the UK from 
http://www.uktis.org/html/maternal_exposure.html, in the US from www.mothertobaby.org and in 
Canada from www.motherisk.org. Information on drug use in breastfeeding is available from 
Lactmed, a US website: http://toxnet.nlm.nih.gov/newtoxnet/lactmed.htm. 
Limitations of the study 
This review was based on a comprehensive search of six databases, but did not search the 
grey literature systematically, and did not attempt to collect any unpublished data, therefore results 
may be subject to a reporting bias, and relevant studies could possibly have been missed. Response 
rates in many of the studies were low, suggesting as a whole the review may have low external 
validity. It is possible that GPs most interested in perinatal mental health responded to the surveys, 
and the views of those who were less interested, or aware, are not represented. This is reflected in 
the differences found, for example, in reported rates of screening, between the survey studies and 
the GP patient record studies. Additionally, the studies included used diverse methodologies, so 
their results were not readily comparable, and no meta-analysis was possible. Differences between 
countries were evident suggesting that findings from one health system might not generalize to 
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other systems or countries. We also included low quality studies in the review, which may affect the 
results.  
Conclusions 
This review of observational studies of GPs’ recognition and treatment of perinatal anxiety and 
depression has exposed substantial gaps in the literature, particularly in relation to anxiety disorders 
and PTSD. GPs reported taking responsibility for recognizing and managing perinatal depression, and 
offering a range of suitable treatments. However, there was substantial variability between studies’ 
methods, outcome measures and geographical location, and low response rates in studies mean it is 
not possible to generalize these results to GPs as a whole.  A limited amount of evidence suggested 
that GP training and knowledge may be potential determinants of positive attitudes towards mental 
health. Future research should examine whether training programs, service developments, and 
improvements to continuity of care have the potential to improve recognition and treatment of 
perinatal depression, and therefore improve outcomes for women. 
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Figure 1. Flow diagram of study selection 
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Table 1: Studies included in the review 
 
Study  Quality 
Score 
Response Rate Country N GPs Main Aim Design Pregnancy/ 
postpartum 
Kean et al., 2011. Scottish 
Medical Journal 30 
12 41% UK 32 GPs Prescribing decisions in 
pregnancy and postpartum 
Postal survey with 
vignettes, questions 
Both 
Alder et al., 2008. Archives of 
Women’s Mental Health 24 
22 72.9% for GP 
practices 
UK 199 GP 
practices 
Adherence to policies around 
PMI in general practice 
Questionnaire Both 
Leiferman et al., 2008. Journal Of 
Women’s Health31 
21 23.9% USA 87 family 
physicians  
Beliefs and practices towards 
postnatal depression  
Online Survey or 
postal questionnaire 
Postpartum  
Leiferman et al., 2010. Depression 
Research and Treatment32 
20 23.9% USA 87 family 
physicians 
Predictors of postnatal 
depression management 
Online survey Postpartum 
Chadha-Hooks et al., 2009. 
Journal of Psychosomatic 
Obstetrics & Gynecology 28 
21 59% USA 26 family 
physicians 
Screening practices for 
postnatal depression 
Survey Postpartum 
Bilszta et al., 2011. Archives of 
Women’s Mental Health 25 
21 79.2% 
Australia 
31.5% Canada 
Australia 
and 
Canada 
96 GPs  Antidepressant use in 
pregnancy 
Scenario plus 
questionnaire 
Pregnancy 
Buist et al., 2005a. Women and 
Birth 27 
22 22.9% Australia 246 GPs  Knowledge and  awareness of 
postnatal depression   
Vignette and 
knowledge 
questionnaire 
Both 
Buist et al., 2005b. Australian 
Family Physician 26 
15 22.9% Australia 246 GPs Recognition and 
management of perinatal 
depression 
Vignette and 
knowledge 
questionnaire 
Both 
Charles et al., 2006. Australian 
Family Physician 29 
10 N/A Australia 411 
entries in 
Management of PND GP patient records Postpartum 
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GP records 
Ververs et al., 2009. BMC Health 
Services Research 33 
20 19% Netherla
nds 
130  GPs Antidepressant use in 
pregnancy 
Questionnaire Pregnancy 
Prady et al., 2016a. Br J Psych 34 22 60.2% of 
women 
recruited in 1 
year sample  
UK GP records 
from 7494 
women  
Prevalence  of anxiety and 
depression, number of cases 
missed in general practice, 
effect of ethnicity 
GP patient records Both 
Prady et al., 2016b. BMC 
Psychiatry 35 
23 17.9% of 
women 
recruited 
UK GP records 
from 2,234 
women 
Prescriptions for anxiety and 
depression in pregnancy and 
replacement therapies, effect 
of ethnicity 
GP patient records Pregnancy 
Seehusen et al., 2005. J Am Board 
Fam Pract 36 
19 60.9% USA 298 GPs Screening for postnatal 
depression 
Questionnaire Postpartum 
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Table 2: Themes and sub-themes drawn from the included studies 
Theme Sub Themes  Kean 
2011 
Alder 
2008 
Leiferman 
2008 
Leiferman 
2010 
Chadha-
Hooks 
2009 
Bilszta 
2011 
Buist 
2005 
Women 
and 
Birth 
Buist 
2005 
Aus 
Fam 
Phys 
Charles 
2006 
Ververs 
2009 
Prady 
2016 
Br J 
Psych 
Prady 
2016 
BMC 
Psych 
Seehusen 
2005  
Assessment 
and 
Recognition of 
Disorders 
Prevalence of 
perinatal 
depression and 
anxiety in 
general 
practice 
  x     x x  x  
 
 Awareness       x x      
 Routine 
enquiry and 
assessment 
 x   x      x  x 
Management 
of Depression 
and Anxiety in 
Pregnancy 
Medication 
choices 
 
x x    x    x  x 
 
Information on 
medication 
choices 
x         x   
 
Management 
of Postnatal 
Depression  
Treatment 
choices 
 
x x x     x x    
 
Determinants 
of Treatment 
Choices 
   x    x     
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Table 3: Proportions of general practitioners and family physicians regularly choosing various 
treatment options for postnatal depression  
Study 
Buist et 
al., 2005 
26 
Alder et 
al., 2008 
24 
Leiferman 
et al., 
2008 31 
Charles et 
al., 2006 
29 
Sample 246 GPs 199 GP 
practices 
87 FPs  411 GP 
encounter
s 
 Country Australia UK USA Australia  
Medication 85% a  92% 57% 
Counseling/Listening by GP   85% a  70% 57% 
Referral      
 To mental health specialist 
 not otherwise specified  32% a  83% 
 
 To psychiatrist    4% 
 To support group   38% 1% 
 For specialized CBT or 
 other psychotherapy 
32% a 51% IPT  
49% CBT  
5% 
Advice on behavior change or 
exercise 
  
61% 7% 
a. Proportions derived from those who would prescribe a combination of medication, counseling and or referral.  
IPT: Interpersonal Therapy; CBT: Cognitive Behavior Therapy  
 
 
